CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
particular disorder or dysfunction (asymptomatic) who have high-risk chronic lymphocytic leukemia or small lymphocytic...
Phase 2
Columbus, Ohio, United States
This study is evaluating the safety and efficacy of the combined use of acalabrutinib and ACP-319, for the treatment of chronic lymphocytic...
Phase 1
Columbus, Ohio, United States and 2 other locations
This study is evaluating the safety and efficacy of a new BTK inhibitor, acalabrutinib, for the treatment of chronic lymphocytic le...
Phase 1, Phase 2
Columbus, Ohio, United States and 11 other locations
treating patients with relapsed, refractory, or previously untreated chronic lymphocytic leukemia, small lymphocytic...
Phase 2
Columbus, Ohio, United States
This phase I trial studies the side effects and best dose of selinexor when given together with ibrutinib in treating patients with chronic ...
Phase 1
Columbus, Ohio, United States and 1 other location
with Obinutuzumab in subjects with relapsed or refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma....
Phase 1
Columbus, Ohio, United States and 14 other locations
This study is designed to evaluate progression-free survival (PFS) endpoint for acalabrutinib versus (vs) ibrutinib in previously treated chronic...
Phase 3
Columbus, Ohio, United States and 130 other locations
The purpose of this study is to compare the efficacy and safety of pirtobruitinib (LOXO-305) to ibrutinib in participants with CLL/SLL. Participants...
Phase 3
Columbus, Ohio, United States and 179 other locations
study includes patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL)/small lymphocytic lympho...
Phase 1, Phase 2
Columbus, Ohio, United States and 74 other locations
The purpose of this single-arm, open-label, Phase 1b/2a, multicenter basket study is to evaluate whether tafasitamab and parsaclisib can be safely co...
Phase 1, Phase 2
Columbus, Ohio, United States and 49 other locations
Clinical trials
Research sites
Resources
Legal